Le Lézard
Classified in: Health

New DOROT Initiative Combats Social Isolation on Evenings and Weekends


NEW YORK, Dec. 11, 2018 /PRNewswire-PRWeb/ -- In an effort to alleviate social isolation among older adults during what many find to be particularly lonely time periods, DOROT has launched a series of Sunday and evening programs. The initiative was piloted last spring with a lineup of five dynamic events including concerts, author presentations and a technology workshop and was met with an enthusiastic response. Two attendees at the first event shared that the programs are a wonderful idea because "the weekend is so long."

The new initiative offers a wide array of cultural, educational and social events designed to appeal to a broad range of interests. The engaging lineup provides stimulating creative arts and intellectual enrichment opportunities. The programs also give participants an often much-needed chance to connect with peers as well as with people of all ages. Events take place twice a month and have so far included sing-alongs, book discussions and intergenerational programming.

"DOROT's new Sunday and Evening Programming initiative is proving to be a wonderful way of expanding DOROT's impact on alleviating social isolation among older adults, particularly those living alone," says Mark L. Meridy, Executive Director. "The dynamic events are not only providing an enjoyable afternoon or evening out but also an important opportunity for participants to socialize with one another."

To learn more about DOROT's Sunday and Evening Programming initiative, contact Dina Zempsky, Senior Program Officer at (917) 441-3747 or check out the programs at http://www.dorotusa.org.

 

SOURCE DOROT


These press releases may also interest you

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...



News published on and distributed by: